Advertisement

Topics

CEL-SCI Corporation - Product Pipeline Review - 2015

05:01 EDT 8 Jun 2015 | BioPortfolio Reports

Recently added to the BioPortfolio report store, CEL-SCI Corporation - Product Pipeline Review - 2015 is a new report from Global Markets Direct published on 2015-04-28. This 40-page report is available in PDF from $1500.

CEL-SCI Corporation - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘CEL-SCI Corporation - Product Pipeline Review - 2015’, provides an overview of the CEL-SCI Corporation’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of CEL-SCI Corporation’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of CEL-SCI Corporation including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of CEL-SCI Corporation’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the CEL-SCI Corporation’s pipeline products

Reasons to buy

- Evaluate CEL-SCI Corporation’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of CEL-SCI Corporation in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the CEL-SCI Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of CEL-SCI Corporation and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to…

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
CEL-SCI Corporation Snapshot 5
CEL-SCI Corporation Overview 5
Key Information 5
Key Facts 5
CEL-SCI Corporation - Research and Development Overview 6
Key Therapeutic Areas 6
CEL-SCI Corporation - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
CEL-SCI Corporation - Pipeline Products Glance 10
CEL-SCI Corporation - Late Stage Pipeline Products 10
Phase III Products/Combination Treatment Modalities 10
CEL-SCI Corporation - Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
CEL-SCI Corporation - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
CEL-SCI Corporation - Drug Profiles 13
Leukocyte Interleukin 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
LEAPS-H1N1-DC 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
CEL-1000 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
CEL-2000 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Vaccine for Breast Cancer 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
CEL-SCI Corporation - Pipeline Analysis 21
CEL-SCI Corporation - Pipeline Products by Target 21
CEL-SCI Corporation - Pipeline Products by Route of Administration 22
CEL-SCI Corporation - Pipeline Products by Molecule Type 23
CEL-SCI Corporation - Pipeline Products by Mechanism of Action 24
CEL-SCI Corporation - Recent Pipeline Updates 25
CEL-SCI Corporation - Dormant Projects 36
CEL-SCI Corporation - Dormant Projects 36
CEL-SCI Corporation - Company Statement 37
CEL-SCI Corporation - Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Appendix 39
Methodology 39
Coverage 39
Secondary Research 39
Primary Research 39
Expert Panel Validation 39
Contact Us 39
Disclaimer 40

For more information open CEL-SCI Corporation - Product Pipeline Review - 2015.

SKU: GMDHC07022CDB

Original Article: CEL-SCI Corporation - Product Pipeline Review - 2015

NEXT ARTICLE

More From BioPortfolio on "CEL-SCI Corporation - Product Pipeline Review - 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...